Breaking News Instant updates and real-time market news.

AXGN

AxoGen

$32.97

0.78 (2.42%)

17:26
11/15/18
11/15
17:26
11/15/18
17:26

AxoGen directorGregory Freitag sells 20K shares of company stock

AxoGen director Gregory Freitag disclosed in a filing that he had sold 20,000 shares of company stock at an average price of $32.25 per share on November 15. The total transaction value of the sale was $645,000.

  • 19

    Nov

AXGN AxoGen
$32.97

0.78 (2.42%)

09/17/18
JEFF
09/17/18
NO CHANGE
Target $45
JEFF
Buy
AxoGen outlook still 'very compelling' despite share selloff, says Jefferies
Despite the recent pullback in the shares, AxoGen's outlook "remains unchanged and very compelling," Jefferies analyst Raj Denhoy tells investors in a research note after meeting with the company, competitors, and surgeons at the American Society for the Surgery of the Hand Annual Meeting. Surgeon acceptance of the company's technologies is increasing, competitors "are more noise than real," and recent execution issues seem resolved, the analyst contends. He believes AxoGen is one of the best positioned growth medtech names and keeps a Buy rating on the shares with a $45 price target.
10/30/18
LEER
10/30/18
NO CHANGE
Target $55
LEER
Outperform
AxoGen price target lowered to $55 from $60 at Leerink
Leerink analyst Richard Newitter lowered his price target for AxoGen to $55 from $60, while reiterating an Outperform rating on the shares as he is encouraged by the company's return to over 40% growth in Q3. Further, the analyst believes the company has significant runway ahead to drive increased adoption into a large underpenetrated existing commercially targeted $2.2B "core" peripheral nerve repair opportunity.
10/30/18
JEFF
10/30/18
NO CHANGE
Target $45
JEFF
Buy
AxoGen remains a top growth idea at Jefferies
Jefferies analyst Raj Denhoy says that after a couple of "choppy quarters," AxoGen posted 41% revenue growth in Q3 and kept 2018 guidance at greater than 40%. The outlook for 2019 was offered up as "at least 35%," which keeps AxoGen among the best medtech growth companies, Denhoy tells investors in a post-earnings research note. He sees an upward bias to 2019 estimates and says the company remains a top growth idea with a Buy rating and $45 price target.
11/14/18
BTIG
11/14/18
INITIATION
BTIG
Neutral
AxoGen initiated with a Neutral at BTIG
BTIG analyst Ryan Zimmerman initiated AxoGen with a Neutral rating, saying that while the company has been "one of the best growth stories in small-cap MedTech", its valuation appears to be fair. The analyst is positive on the company's peripheral nerve repair products which, as he claims, show "superiority against the standard of care". Zimmerman also points to AxoGen's market opportunity in breast, pain, and oral/maxillofacial surgery areas that imply a runway for AxoGen's future revenue growth.

TODAY'S FREE FLY STORIES

XLB

S&P Select Materials SPDR

$57.43

-0.37 (-0.64%)

08:18
04/23/19
04/23
08:18
04/23/19
08:18
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$57.23

-0.06 (-0.10%)

08:18
04/23/19
04/23
08:18
04/23/19
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NMRD

Nemaura Medical

$0.98

-0.06 (-5.77%)

08:18
04/23/19
04/23
08:18
04/23/19
08:18
Hot Stocks
Nemaura Medical completes two usability studies for SugarBEAT »

Nemaura Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$56.87

0.01 (0.02%)

08:18
04/23/19
04/23
08:18
04/23/19
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$85.97

0.07 (0.08%)

08:18
04/23/19
04/23
08:18
04/23/19
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$34.39

-0.01 (-0.03%)

08:18
04/23/19
04/23
08:18
04/23/19
08:18
Recommendations
Twitter analyst commentary at Baird »

Twitter Q2 guidance looks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 20

    May

IWM

iShares Trust Russell 2000 Index Fund

$155.19

-0.44 (-0.28%)

08:17
04/23/19
04/23
08:17
04/23/19
08:17
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$265.04

-0.48 (-0.18%)

08:17
04/23/19
04/23
08:17
04/23/19
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STT

State Street

$69.92

-0.02 (-0.03%)

08:17
04/23/19
04/23
08:17
04/23/19
08:17
Hot Stocks
State Street says still targeting 4% productivity savings in FY19 »

Says "well…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 15

    May

  • 11

    Jun

SPY

SPDR S&P 500 ETF Trust

$290.30

0.31 (0.11%)

08:17
04/23/19
04/23
08:17
04/23/19
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$27.26

-0.08 (-0.29%)

08:17
04/23/19
04/23
08:17
04/23/19
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$117.63

-0.11 (-0.09%)

08:16
04/23/19
04/23
08:16
04/23/19
08:16
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

Invesco QQQ Trust

$187.91

0.54 (0.29%)

08:16
04/23/19
04/23
08:16
04/23/19
08:16
Technical Analysis
Invesco QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$COMP

Nasdaq Composite

$0.00

(0.00%)

08:16
04/23/19
04/23
08:16
04/23/19
08:16
Technical Analysis
Nasdaq Composite: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LH

LabCorp

$144.26

-0.94 (-0.65%)

08:16
04/23/19
04/23
08:16
04/23/19
08:16
Hot Stocks
LabCorp announces extension of distribution agreement with OmniSeq »

OmniSeq and LabCorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 09

    May

  • 23

    May

LMT

Lockheed Martin

$315.24

0.94 (0.30%)

08:16
04/23/19
04/23
08:16
04/23/19
08:16
Hot Stocks
Lockheed Martin raises FY19 Segment Operating Profit to $6.10B-$6.25B »

Prior guidance for FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 25

    Apr

  • 29

    May

  • 05

    Jun

NDX

Nasdaq 100 Index

$0.00

(0.00%)

08:16
04/23/19
04/23
08:16
04/23/19
08:16
Technical Analysis
Nasdaq 100 Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVFM

Evofem

$4.25

0.23 (5.72%)

08:13
04/23/19
04/23
08:13
04/23/19
08:13
Hot Stocks
Evofem completes patient enrollment in Phase 2b clinical trial of Amphora »

Evofem Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHEN

Shenandoah

$42.74

0.46 (1.09%)

08:13
04/23/19
04/23
08:13
04/23/19
08:13
Hot Stocks
Shenandoah CFO James Woodward to resign »

Shenandoah announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$34.39

-0.01 (-0.03%)

08:12
04/23/19
04/23
08:12
04/23/19
08:12
Hot Stocks
Twitter says first priority is still 'health,' focused on proactive detection »

For products, says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 20

    May

V

Visa

$160.39

0.25 (0.16%)

, MA

MasterCard

$243.00

2.02 (0.84%)

08:10
04/23/19
04/23
08:10
04/23/19
08:10
Recommendations
Visa, MasterCard analyst commentary at Morgan Stanley »

Visa, MasterCard price…

V

Visa

$160.39

0.25 (0.16%)

MA

MasterCard

$243.00

2.02 (0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 30

    Apr

  • 07

    May

  • 09

    May

  • 14

    May

  • 18

    May

  • 29

    May

  • 03

    Jun

  • 05

    Jun

  • 11

    Jun

  • 25

    Jun

TRCB

Two River Bancorp

$15.08

(0.00%)

08:10
04/23/19
04/23
08:10
04/23/19
08:10
Earnings
Two River Bancorp reports Q1 EPS 32c, two estimates 31c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

KMB

Kimberly-Clark

$130.24

6.76 (5.47%)

08:10
04/23/19
04/23
08:10
04/23/19
08:10
Upgrade
Kimberly-Clark rating change at Argus »

Kimberly-Clark upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 06

    May

  • 29

    May

  • 23

    Jul

08:10
04/23/19
04/23
08:10
04/23/19
08:10
General news
Oil Action: WTI crude »

Oil Action: WTI crude…

AES

AES Corp.

$17.69

-0.025 (-0.14%)

08:09
04/23/19
04/23
08:09
04/23/19
08:09
Hot Stocks
AES Corp. enters agreements to sell interests in Jordan, UK power plants »

The AES Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 13

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.